Skip to Main Content

Imaging brain activation using FDG-fPET

  • Study HIC#:2000035067
  • Last Updated:11/06/2025
  • The purpose of this study is to is to study the activation in your brain using FDG functional PET imaging (FDG-fPET). The radiotracer 18F-FDG is an analog of glucose and can be used to measure glucose uptake in regions of the brain at rest and during stimulation. FDG is an FDA approved Positron Emission Tomography (PET) tracer that is routinely used in clinical imaging to measure glucose uptake. We will be using an imaging technique called PET (Positron Emission Tomography), which can track the movement of the radiotracer in the body.

    Contact Us

    For more information about this study, including how to volunteer, contact:

    Mark Dias

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

    Eligibility Criteria

    Adult male and female healthy subjects, aged 18-80, who meet the inclusion criteria, and who do not meet any of the exclusion criteria will be eligible for enrollment into the study.

    Principal Investigator

    Sub-Investigators

    For more information about this study, including how to volunteer, contact: